Home     About ViagraCongress     Solutions     Services     Leadership     HIPAA     Accolades     ViagraCongressRx  

ViagraCongress uses reports produced with our cutting edge tools to document potential savings for customers providing opportunities to increase cost reductions.

After reviewing the Duration of therapy limit on Proton Pump Inhibitors with several customers, ViagraCongress found a potential savings of $0.65 to $1.30 PMPM by limiting PPI use to 90 days.

We have developed a benchmark report that will show standard performance measures across multiple customers so that you can see how your plan is performing relative to similar plans.